Acibadem City Clinic Tokuda Hospital is the largest medical facility in Bulgaria, built and developed with private investments. It was opened in 2006 as part of a Japanese medical group, owned by the physician and entrepreneur Dr. Torao Tokuda.

During the past decade, "City Clinic UMHAC" EOOD conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 36 clinical trials were completed, i.e. on average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 29 clinical trials were completed. i.e. 241.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in ""City Clinic UMHAC" EOOD" #1 sponsor was "Pfizer" with 12 trials, followed by "Celgene" with 9 trials sponsored, "Hoffmann-La Roche" with 9 trials sponsored, "Bayer" with 6 trials sponsored and "Takeda" with 6 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in ""City Clinic UMHAC" EOOD" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in ""City Clinic UMHAC" EOOD" are "Ulcerative Colitis" (15 trials), "Crohn Disease" (7 trials), "Crohn's Disease" (6 trials), "Colitis, Ulcerative" (4 trials) and "Dermatitis, Atopic" (3 trials). Many other conditions were trialed in ""City Clinic UMHAC" EOOD" in a lesser frequency.

Most popular intervention types in ""City Clinic UMHAC" EOOD" are "Drug" (73 trials), "Other" (13 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (38 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (4 trials). Other intervention names were less common.

The vast majority of trials in ""City Clinic UMHAC" EOOD" are 76 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in ""City Clinic UMHAC" EOOD". undefined are not yet recruiting, 12 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in "City Clinic UMHAC" EOOD, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in "City Clinic UMHAC" EOOD, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

"City Clinic UMHAC" EOOD has several departments that took part in Clinical trials: "City Clinic Burgas" - 3 trials